CD4 and neoplasm: Nevertheless, several studies have demonstrated that tumor cell-derived EVs could carry tumor antigens and then promote tumor immunity through CD8(+) and CD4(+) T cells, which could kill tumor cells and frustrate the progression of tumors [64].